vs
Astrana Health, Inc.（ASTH）とQuanex Building Products CORP（NX）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $495.3M、Quanex Building Products CORPの約1.9倍）。Astrana Health, Inc.の純利益率が高く（0.7% vs -55.7%、差は56.4%）。Quanex Building Products CORPの前年同期比売上増加率が高い（76.7% vs 42.9%）。Quanex Building Products CORPの直近四半期フリーキャッシュフローが多い（$46.2M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 29.5%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
Quanex Building Products Corporationは、エンジニアリングされた建築部品・資材の大手製造企業です。主な製品には断熱ガラス用スペーサー、窓・ドアシステム、キ�ビネット・家具部品があり、北米・欧州の住宅・商業建築市場向けに省エネで持続可能な建築ソリューションを提供しています。
ASTH vs NX — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $495.3M |
| 純利益 | $6.6M | $-276.0M |
| 粗利率 | — | 27.9% |
| 営業利益率 | 1.9% | -54.7% |
| 純利益率 | 0.7% | -55.7% |
| 売上前年比 | 42.9% | 76.7% |
| 純利益前年比 | 184.4% | -1188.8% |
| EPS（希薄化後） | $0.12 | $-6.04 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $495.3M | ||
| Q2 25 | $654.8M | $452.5M | ||
| Q1 25 | $620.4M | $400.0M | ||
| Q4 24 | $665.2M | $492.2M | ||
| Q3 24 | $478.7M | $280.3M | ||
| Q2 24 | $486.3M | $266.2M | ||
| Q1 24 | $404.4M | $239.2M |
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $-276.0M | ||
| Q2 25 | $9.4M | $20.5M | ||
| Q1 25 | $6.7M | $-14.9M | ||
| Q4 24 | $-7.8M | $-13.9M | ||
| Q3 24 | $16.1M | $25.4M | ||
| Q2 24 | $19.2M | $15.4M | ||
| Q1 24 | $14.8M | $6.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | 27.9% | ||
| Q2 25 | — | 29.0% | ||
| Q1 25 | — | 23.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 25.3% | ||
| Q2 24 | — | 24.9% | ||
| Q1 24 | — | 21.5% |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | -54.7% | ||
| Q2 25 | 3.1% | 9.0% | ||
| Q1 25 | 3.3% | -1.7% | ||
| Q4 24 | 0.1% | 0.6% | ||
| Q3 24 | 5.9% | 8.4% | ||
| Q2 24 | 6.2% | 7.8% | ||
| Q1 24 | 7.5% | 3.3% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | -55.7% | ||
| Q2 25 | 1.4% | 4.5% | ||
| Q1 25 | 1.1% | -3.7% | ||
| Q4 24 | -1.2% | -2.8% | ||
| Q3 24 | 3.4% | 9.0% | ||
| Q2 24 | 3.9% | 5.8% | ||
| Q1 24 | 3.7% | 2.6% |
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | $-6.04 | ||
| Q2 25 | $0.19 | $0.44 | ||
| Q1 25 | $0.14 | $-0.32 | ||
| Q4 24 | $-0.14 | $-0.52 | ||
| Q3 24 | $0.33 | $0.77 | ||
| Q2 24 | $0.40 | $0.46 | ||
| Q1 24 | $0.31 | $0.19 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $66.3M |
| 総負債低いほど良い | — | $695.6M |
| 株主資本純資産 | $779.3M | $717.4M |
| 総資産 | $2.2B | $2.0B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.97× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | $66.3M | ||
| Q2 25 | $342.1M | $62.6M | ||
| Q1 25 | $260.9M | $50.0M | ||
| Q4 24 | $290.8M | $97.7M | ||
| Q3 24 | $350.3M | $94.0M | ||
| Q2 24 | $327.7M | $56.1M | ||
| Q1 24 | $337.3M | $44.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $695.6M | ||
| Q2 25 | — | $746.4M | ||
| Q1 25 | — | $725.2M | ||
| Q4 24 | — | $737.2M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.5M | ||
| Q1 24 | — | $61.6M |
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $717.4M | ||
| Q2 25 | $765.5M | $1.0B | ||
| Q1 25 | $745.4M | $972.1M | ||
| Q4 24 | $712.7M | $1.0B | ||
| Q3 24 | $704.6M | $594.1M | ||
| Q2 24 | $678.9M | $566.1M | ||
| Q1 24 | $653.5M | $555.0M |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $2.0B | ||
| Q2 25 | $1.4B | $2.3B | ||
| Q1 25 | $1.3B | $2.2B | ||
| Q4 24 | $1.4B | $2.3B | ||
| Q3 24 | $1.3B | $872.5M | ||
| Q2 24 | $1.3B | $837.2M | ||
| Q1 24 | $1.2B | $813.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.09× | ||
| Q1 24 | — | 0.11× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $60.7M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $46.2M |
| FCFマージンFCF / 売上 | -0.6% | 9.3% |
| 設備投資強度設備投資 / 売上 | 0.3% | 2.9% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | — |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $27.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $60.7M | ||
| Q2 25 | $90.9M | $28.5M | ||
| Q1 25 | $16.6M | $-12.5M | ||
| Q4 24 | $-10.9M | $5.5M | ||
| Q3 24 | $34.0M | $46.4M | ||
| Q2 24 | $23.2M | $33.1M | ||
| Q1 24 | $6.0M | $3.9M |
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $46.2M | ||
| Q2 25 | $89.5M | $13.6M | ||
| Q1 25 | $13.6M | $-24.1M | ||
| Q4 24 | $-13.5M | $-8.2M | ||
| Q3 24 | $31.7M | $40.1M | ||
| Q2 24 | $20.4M | $25.5M | ||
| Q1 24 | $5.6M | $-5.7M |
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | 9.3% | ||
| Q2 25 | 13.7% | 3.0% | ||
| Q1 25 | 2.2% | -6.0% | ||
| Q4 24 | -2.0% | -1.7% | ||
| Q3 24 | 6.6% | 14.3% | ||
| Q2 24 | 4.2% | 9.6% | ||
| Q1 24 | 1.4% | -2.4% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 2.9% | ||
| Q2 25 | 0.2% | 3.3% | ||
| Q1 25 | 0.5% | 2.9% | ||
| Q4 24 | 0.4% | 2.8% | ||
| Q3 24 | 0.5% | 2.2% | ||
| Q2 24 | 0.6% | 2.9% | ||
| Q1 24 | 0.1% | 4.0% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 1.39× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 1.83× | ||
| Q2 24 | 1.21× | 2.15× | ||
| Q1 24 | 0.40× | 0.62× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
NX
| Window And Door Hardware | $150.3M | 30% |
| Screens | $76.8M | 16% |
| Window Profiles | $68.2M | 14% |
| Spacers | $54.7M | 11% |
| Wood Solutions | $53.4M | 11% |
| Seals And Gaskets | $29.9M | 6% |
| Access Solutions | $27.4M | 6% |
| Mixing Solution | $21.5M | 4% |
| Solar | $5.3M | 1% |
| Product Type Other | $3.3M | 1% |
